Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the study is currently e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dermatomyositis
• Juvenile Idiopathic Arthritis
• Polymyositis
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• Mesenchymal Stem Cell Infusion

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE) | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION